MAB802 (MRG002 antibody) is a recombinant humanized anti-HER2 monoclonal antibody. It shares the same amino acid sequence as Trastuzumab but is highly fucosylated. The antibody-dependent cell-mediated cytotoxicity (ADCC) activity of MAB802 is comparatively lower. MAB802 is employed as the antibody component in the antibody-drug conjugate Trastuzumab vedotin (MRG002).
Target:
EGFR|||ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted